Compare Procter & Gamble Health with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs WYETH LTD - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH WYETH LTD PROCTER & GAMBLE HEALTH/
WYETH LTD
 
P/E (TTM) x 43.3 27.7 156.2% View Chart
P/BV x 4.5 5.3 83.4% View Chart
Dividend Yield % 10.6 1.3 834.4%  

Financials

 PROCTER & GAMBLE HEALTH   WYETH LTD
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
WYETH LTD
Mar-13
PROCTER & GAMBLE HEALTH/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs3,5491,044 339.8%   
Low Rs1,301818 159.1%   
Sales per share (Unadj.) Rs511.4298.6 171.3%  
Earnings per share (Unadj.) Rs61.357.2 107.1%  
Cash flow per share (Unadj.) Rs74.058.4 126.7%  
Dividends per share (Unadj.) Rs440.0017.00 2,588.2%  
Dividend yield (eoy) %18.11.8 993.8%  
Book value per share (Unadj.) Rs927.8249.5 371.9%  
Shares outstanding (eoy) m16.6022.72 73.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.73.1 152.0%   
Avg P/E ratio x39.616.3 243.2%  
P/CF ratio (eoy) x32.815.9 205.5%  
Price / Book Value ratio x2.63.7 70.0%  
Dividend payout %717.929.7 2,417.3%   
Avg Mkt Cap Rs m40,25721,157 190.3%   
No. of employees `0001.10.5 230.5%   
Total wages/salary Rs m1,313400 328.2%   
Avg. sales/employee Rs Th7,486.713,787.4 54.3%   
Avg. wages/employee Rs Th1,157.6813.0 142.4%   
Avg. net profit/employee Rs Th897.22,643.3 33.9%   
INCOME DATA
Net Sales Rs m8,4906,783 125.2%  
Other income Rs m244353 69.2%   
Total revenues Rs m8,7347,136 122.4%   
Gross profit Rs m1,4821,617 91.6%  
Depreciation Rs m21127 794.0%   
Interest Rs m06 0.0%   
Profit before tax Rs m1,5141,938 78.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m66-5 -1,286.3%   
Tax Rs m563632 89.0%   
Profit after tax Rs m1,0171,301 78.2%  
Gross profit margin %17.523.8 73.2%  
Effective tax rate %37.132.6 113.9%   
Net profit margin %12.019.2 62.5%  
BALANCE SHEET DATA
Current assets Rs m15,3436,984 219.7%   
Current liabilities Rs m1,9602,056 95.3%   
Net working cap to sales %157.672.6 217.0%  
Current ratio x7.83.4 230.4%  
Inventory Days Days4999 49.1%  
Debtors Days Days2824 118.8%  
Net fixed assets Rs m1,209244 495.0%   
Share capital Rs m166227 73.1%   
"Free" reserves Rs m15,2355,441 280.0%   
Net worth Rs m15,4015,668 271.7%   
Long term debt Rs m025 0.0%   
Total assets Rs m17,5957,901 222.7%  
Interest coverage xNM353.3-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.9 56.2%   
Return on assets %5.816.5 35.0%  
Return on equity %6.622.9 28.8%  
Return on capital %10.334.0 30.1%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m1,63615 10,765.1%   
Fx outflow Rs m4,3682,677 163.2%   
Net fx Rs m-2,732-2,662 102.6%   
CASH FLOW
From Operations Rs m-1,304923 -141.2%  
From Investments Rs m12,697317 4,006.7%  
From Financial Activity Rs m-301-481 62.5%  
Net Cashflow Rs m11,093759 1,461.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 51.1 101.4%  
Indian inst/Mut Fund % 18.2 11.3 161.1%  
FIIs % 1.0 7.2 13.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 30.4 95.7%  
Shareholders   28,591 21,978 130.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   J.B.CHEMICALS  SUVEN LIFESCIENCES  STERLING BIOTECH  CADILA HEALTHCARE  ALEMBIC LTD  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; FMCG and Metal Stocks Gain(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 2% while the Hang Seng is down 0.3%.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

These Rebirth of India Stocks Are Raring to Compete with Tesla(The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

Corona Virus Could Trigger a Rally in this Stock(Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Feb 25, 2020 11:03 AM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS